- JP-listed companies
- Kitazato Corporation
- Financials
- Operating margin (%)
Kitazato Corporation (368A)
Market cap
¥48B
P/E ratio
12.1x
Kitasato Corporation develops and manufactures medical devices and reagents for reproductive medicine including IVF and egg freezing, serving hospitals and clinics in over 110 countries worldwide.
| Period End | Operating margin (%) | YoY (%) |
|---|---|---|
| Mar 31, 2026 | 53.5 | -4.66% |
| Mar 31, 2025 | 56.1 | -4.31% |
| Mar 31, 2024 | 58.7 | +6.92% |
| Mar 31, 2023 | 54.9 |